[
    [
        {
            "time": "",
            "original_text": "【新康界每周投资策略】医药生物行业分析系列——第三方医学诊断（实验室）（ICL）",
            "features": {
                "keywords": [
                    "新康界",
                    "投资策略",
                    "医药生物",
                    "第三方医学诊断",
                    "实验室",
                    "ICL"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【新康界每周投资策略】医药生物行业分析系列——第三方医学诊断（实验室）（ICL）",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【新康界每周投资策略】科创板细则落地，或可分拆上市的医药上市公司有哪些？",
            "features": {
                "keywords": [
                    "新康界",
                    "投资策略",
                    "科创板",
                    "细则落地",
                    "分拆上市",
                    "医药上市公司"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【新康界每周投资策略】科创板细则落地，或可分拆上市的医药上市公司有哪些？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]